期刊文献+

套细胞淋巴瘤的临床病理特征及预后因素分析 被引量:14

Mantle cell lymphoma:clinicopathologic features and prognostic factors of 102 cases occurring in
原文传递
导出
摘要 目的探讨套细胞淋巴瘤(MCL)的临床病理特征及预后因素。方法对102例经形态学及免疫表型检测确定的 MCL 进行分析,组织病理制片和链霉素抗生物素蛋白过氧化物酶法或EnVision 法染色,并进行了随访。结果 102例患者中位年龄59岁(30~79岁),男女之比约2.92:1。淋巴结是最常受累的部位(98/98,100%),结外常受累的部位:骨髓(29/45,64.4%)、脾脏(36/57,63.2%)、咽淋巴环(15/48,31.3%)、外周血(15/51,29.4%)、肝脏(12/53,22.6%)及胃肠道(15/102,14.7%);87.7%(71/81)初次就诊时处于临床Ⅲ~Ⅳ期,45.5%(25/55)患者有 B 症状;48.7%(19/39)患者血清乳酸脱氢酶升高。除7例(6.9%)因组织取材小无法区分病变模式外,余95例中12例(11.76%)为套区增生型,41例(40.2%)结节型,42例(41.2%)弥漫型。75.5%(77)经典型,24.5%(25例)瘤细胞呈母细胞样变型。102例均表达 B 细胞标记而不表达 T 细胞标记,96例(94.1%)肿瘤细胞表达细胞周期蛋白 D1,70例(71.4%)CD5弱阳性。68例获得随访,中位生存时间10个月(0~89个月)。套区增生型+结节型、经典型的核分裂象≤15/10 HPF,增殖指数≤15%;骨髓无受累,提示患者预后好,而其他临床病理因素对患者生存未见影响。结论国内 MCL 患者病征与国外患者基本一致,其病变模式、细胞变型、核分裂象、增殖指数、骨髓是否受累及受累程度与预后有关。 Objective To study the clinicopathologic features and prognostic factors of Chinese patients with mantle cell lymphoma. Methods One hundred and two cases of mantle cell lymphoma occurring in Chinese patients were studied by light microscopy and immunohistochemistry. The follow-up information was also analyzed. The cases were classified as mantle zone, nodular or diffuse patterns and as typical or blastoid variants. Age, Ann-Arbor staging, B symptoms, hematologic parameters, histologic variants, mitotic index and immunophenotype were assessed for possible prognostic implication. Results The median age of the patients was 59 years ( range. 30 to 79 years ) and the male-to-female ratio was 2.92: 1. Seventy-one patients (87. 65% ) presented with advanced stage disease (Ann Arbor stage Ⅲ to Ⅳ). B symptoms were present in 45.45% of patients. The commonest site of involvement was lymph node ( 100% ). The other involved sites included bone marrow (64. 44% ), spleen (63.16%), Waldeyer's ring (31.25%), peripheral blood (29.41%), liver (22. 64% ) and gastrointestinal tract ( 14. 71% ). All cases expressed B-cell markers but were negative for T-cell marker. Majority of cases were positive for cyclin DI (94. 12%) and CD5 (71.43%). Blastoid variant accounted for 24.51% of cases. Amongst the 68cases with follow-up data available, the median survival was 10 months. Parameters associated with shorter survival included diffuse pattern, blastoid variant, high mitotic index, high proliferative activity and presence of bone marrow involvement. Conclusions The clinicopathologic features and prognostic factors of mantle cell lymphoma occurring in Chinese are similar to those in Caucasians. Diffuse pattern, blastoid variant, high mitotic index, high proliferative activity and involvement of bone marrow indicate poor prognosis.
出处 《中华病理学杂志》 CAS CSCD 北大核心 2007年第11期730-735,共6页 Chinese Journal of Pathology
关键词 淋巴瘤 膜细胞 细胞周期蛋白D1 诊断 预后 Lymphoma,mantle-cell Cyclin D1 Diagnosis Prognosis
  • 相关文献

参考文献20

  • 1SwerdlowSH, Nathwani BN, Berger F, et al. Mantle cell lymphoma.//Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001:168-170.
  • 2Weisenburger DD, Armitage JO. Mantle cell lymphoma-an entity comes of age. Blood, 1996, 87(11 ) : 4483-4494.
  • 3Campo E, Raffeld M, Jaffe ES. Mantle cell lymphoma. Semin Hematol,1999, 36 (2): 115-127.
  • 4Swerdlow SH, Williams ME. From centrocytic to mantle cell lymphoma : a clinicopathologic and molecular review of 3 decades. Hum Pathol, 2002, 33 ( 1 ) : 7-20.
  • 5徐世麟 李甘地 等.外套层淋巴瘤一例报告[J].四川科学院学报,1984,15:153-158.
  • 6何小金,李甘地,刘卫平,林友胜,李俸媛,廖殿英.套细胞淋巴瘤的临床病理特征和细胞周期蛋白D1在诊断中的意义[J].中华病理学杂志,2002,31(4):300-304. 被引量:15
  • 7何小金,李甘地,刘卫平,李海燕,杨文秀,李俸媛.细胞周期蛋白D1表达、聚合酶链反应及荧光原位杂交检测t(11;14)(q13;q32)易位在套细胞淋巴瘤诊断中的应用[J].中华病理学杂志,2004,33(5):487-490. 被引量:4
  • 8Majlis A, Pugh WC, Rodriguez MA, et al. Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants. J Clin Oncol, 1997, 15 (4) :1664- 1671.
  • 9Argatoff LH, Connors JM, Klasa RJ, et al. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood, 1997, 89 (6) : 2067-2078.
  • 10Bosch F, Lopez-Guillermo A, Campo E, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer,1998, 82(3) :567-575.

二级参考文献35

  • 1张彦宁,周小鸽,张淑红,王鹏,张长淮,黄受方.非霍奇金B细胞淋巴瘤369例病理形态观察 2001年世界卫生组织淋巴组织肿瘤新分类应用体会[J].中华病理学杂志,2005,34(4):193-197. 被引量:36
  • 2徐世麟 李甘地 等.外套层淋巴瘤一例报告[J].四川科学院学报,1984,15:153-158.
  • 3Leroux D, Le Marc′Hadour F, Gressin R, et al. Non-Hodgkin′s lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol,1991,77:346-353.
  • 4Raynaud SD, Bekri S, Leroux D, et al. Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chromosomes Cancer,1993,8:80-87.
  • 5Tsujimoto Y, Yunis J, Onorato-Showe L, et al. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science,1984,224:1403-1406.
  • 6Pinyol M, Campo E, Nadal A, et al. Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissue of mantle cell lymphomas by polymerase chain reaction. Am J Clin Pathol,1996,105:532-537.
  • 7Remstein ED, Kurtin PJ, Buno I, et al. Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol,2000,110:856-862.
  • 8Belaud-Rotureau MA, Parrens M, Dubus P, et al. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol, 2002, 15:517-525.
  • 9Zukerberg LR, Yang WI, Arnold A, et al. Cyclin D1 expression in non-Hodgkin′s lymphomas. Detection by immunohistochemistry. Am J Clin Pathol, 1995,103:756-760.
  • 10de Boer CJ, Schuuring E, Dreef E, et al. Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood, 1995,86:2715-2723.

共引文献21

同被引文献188

引证文献14

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部